D., Dziedzic, A., Kpa, M., Kubina, R., Kabaa-Dzik, A., Mularz, T., & Idzik, D
Chronic kidney disease and the gut microbiome
Shifting paradigms: Reframing coverage of antiobesity medications for plan sponsors
All covered GLP-1 drugs are available for a flat $50 copay, regardless of which drug is prescribed
The MDL is advancing through coordinated discovery as attorneys prepare the groundwork for early bellwether trials that could help gauge how juries respond to evidence linking the drugs to severe digestive injuries
Alcohol is a neurotoxin